These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37669567)

  • 1. Expansion of Anticomplement Therapy Indications from Rare Genetic Disorders to Common Kidney Diseases.
    Miwa T; Sato S; Golla M; Song WC
    Annu Rev Med; 2024 Jan; 75():189-204. PubMed ID: 37669567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement and kidney disease.
    Cook HT
    Curr Opin Nephrol Hypertens; 2013 May; 22(3):295-301. PubMed ID: 23508058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Rare Inflammatory Kidney Diseases: Drugs Targeting the Terminal Complement Pathway.
    Anliker-Ort M; Dingemanse J; van den Anker J; Kaufmann P
    Front Immunol; 2020; 11():599417. PubMed ID: 33362783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement and glomerular diseases.
    Popat RJ; Robson MG
    Nephron Clin Pract; 2014; 128(3-4):238-42. PubMed ID: 25412932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The complement cascade and renal disease.
    Kościelska-Kasprzak K; Bartoszek D; Myszka M; Zabińska M; Klinger M
    Arch Immunol Ther Exp (Warsz); 2014 Feb; 62(1):47-57. PubMed ID: 24030732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecules Great and Small: The Complement System.
    Mathern DR; Heeger PS
    Clin J Am Soc Nephrol; 2015 Sep; 10(9):1636-50. PubMed ID: 25568220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Role of Complement in Kidney Diseases - New Aspects].
    Zipfel PF; Zipfel S; Wiech T
    Dtsch Med Wochenschr; 2023 Jun; 148(12):774-779. PubMed ID: 37257480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inherited Kidney Complement Diseases.
    Lemaire M; Noone D; Lapeyraque AL; Licht C; Frémeaux-Bacchi V
    Clin J Am Soc Nephrol; 2021 Jun; 16(6):942-956. PubMed ID: 33536243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving Clinical Trials for Anticomplement Therapies in Complement-Mediated Glomerulopathies: Report of a Scientific Workshop Sponsored by the National Kidney Foundation.
    Bomback AS; Appel GB; Gipson DS; Hladunewich MA; Lafayette R; Nester CM; Parikh SV; Smith RJH; Trachtman H; Heeger PS; Ram S; Rovin BH; Ali S; Arceneaux N; Ashoor I; Bailey-Wickins L; Barratt J; Beck L; Cattran DC; Cravedi P; Erkan E; Fervenza F; Frazer-Abel AA; Fremeaux-Bacchi V; Fuller L; Gbadegesin R; Hogan JJ; Kiryluk K; le Quintrec-Donnette M; Licht C; Mahan JD; Pickering MC; Quigg R; Rheault M; Ronco P; Sarwal MM; Sethna C; Spino C; Stegall M; Vivarelli M; Feldman DL; Thurman JM
    Am J Kidney Dis; 2022 Apr; 79(4):570-581. PubMed ID: 34571062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C3 glomerulopathy and atypical hemolytic uremic syndrome: an updated review of the literature on alternative complement pathway disorders.
    Turkmen K; Baloglu I; Ozer H
    Int Urol Nephrol; 2021 Oct; 53(10):2067-2080. PubMed ID: 33389509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The complement system in pediatric acute kidney injury.
    Stenson EK; Kendrick J; Dixon B; Thurman JM
    Pediatr Nephrol; 2023 May; 38(5):1411-1425. PubMed ID: 36203104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of anticomplement therapy in lupus nephritis.
    Fernandez-Ruiz R; Belmont HM
    Transl Res; 2022 Jul; 245():1-17. PubMed ID: 35158097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Complement factor B mutation in atypical hemolytic uremic syndrome. Rare cause of rare disease].
    Visconti L; Cernaro V; Ardissino G; Sgarbanti M; Ferrara D; Visconti G; Santoro D; Buemi M
    G Ital Nefrol; 2017 Apr; 34(2):74-81. PubMed ID: 28682564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel roles of complement in renal diseases and their therapeutic consequences.
    Wada T; Nangaku M
    Kidney Int; 2013 Sep; 84(3):441-50. PubMed ID: 23615508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factor D Inhibition Blocks Complement Activation Induced by Mutant Factor B Associated With Atypical Hemolytic Uremic Syndrome and Membranoproliferative Glomerulonephritis.
    Aradottir SS; Kristoffersson AC; Roumenina LT; Bjerre A; Kashioulis P; Palsson R; Karpman D
    Front Immunol; 2021; 12():690821. PubMed ID: 34177949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gain-of-Function Mutations R249C and S250C in Complement C2 Protein Increase C3 Deposition in the Presence of C-Reactive Protein.
    Urban A; Kowalska D; Stasiłojć G; Kuźniewska A; Skrobińska A; Arjona E; Alonso EC; Fenollosa Segarra MÁ; Jongerius I; Spaapen R; Satchell S; Thiel M; Ołdziej S; Rodriguez de Córdoba S; Okrój M
    Front Immunol; 2021; 12():724361. PubMed ID: 34899688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetics of Immune-Mediated Glomerular Diseases: Focus on Complement.
    Noris M; Remuzzi G
    Semin Nephrol; 2017 Sep; 37(5):447-463. PubMed ID: 28863792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement Inhibitors in Clinical Trials for Glomerular Diseases.
    Zipfel PF; Wiech T; Rudnick R; Afonso S; Person F; Skerka C
    Front Immunol; 2019; 10():2166. PubMed ID: 31611870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary complement biomarkers in immune-mediated kidney diseases.
    Kesarwani V; Bukhari MH; Kahlenberg JM; Wang S
    Front Immunol; 2024; 15():1357869. PubMed ID: 38895123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overactivity of Alternative Pathway Convertases in Patients With Complement-Mediated Renal Diseases.
    Michels MAHM; van de Kar NCAJ; Okrój M; Blom AM; van Kraaij SAW; Volokhina EB; van den Heuvel LPWJ
    Front Immunol; 2018; 9():612. PubMed ID: 29670616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.